Keywords: NAB، آنتی بادی خنثی می کند; ADA, anti-drug antibody; MAb, monoclonal antibody; NAb, neutralizing antibody; CLB, competitive ligand binding; MRD, minimal required dilution; PC, positive control; PHS, pooled human serum; MAb, monoclonal antibody; IC50, half of maximal inhibitory conce
مقالات ISI NAB، آنتی بادی خنثی می کند (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: NAB، آنتی بادی خنثی می کند; ADA, anti-drug antibody; CAST, customized assay statistical tool; ACP, screening assay cut point; DCP, depletion cut point; ECL, electrochemiluminescence; S/N, signal to noise ratio; NC, negative control; NAb, neutralizing antibody; Log, logarithm; ANOVA,
Development and validation of a novel cell-based assay for potency determination of human parathyroid hormone (PTH)
Keywords: NAB، آنتی بادی خنثی می کند; cAMP, cyclic adenosine mono-phosphate; DMEM, Dulbecco's Modified Eagle Medium; FCS, fetal calf serum; NAB, neutralizing antibody; NIBSC, National Institute for Biological Standards and Control; P, cell passage number; PTH, parathyroid hormone; PTHR1, para
Recommendations for the validation of cell-based assays used for the detection of neutralizing antibody immune responses elicited against biological therapeutics
Keywords: NAB، آنتی بادی خنثی می کند; ADA, anti-drug antibody; NAb, neutralizing antibody; FDA, Food and Drug Administration; EMEA, European Medicines Agency; ICH, International Conference on Harmonization; PC, positive control; LPC, low positive control; HPC, high positive control; SD, stand
A novel gamma-fitting statistical method for anti-drug antibody assays to establish assay cut points for data with non-normal distribution
Keywords: NAB، آنتی بادی خنثی می کند; ADA, anti-drug antibody; ATA, anti-therapeutic antibody; CP, cut point; NAB, neutralizing antibody; CF, cut point correction factor; NC, negative control; EDF, empirical distribution function-type statistical tests of normality; MLE, maximum likelihood es
Development and optimization of a cell-based neutralizing antibody assay using a sample pre-treatment step to eliminate serum interference
Keywords: NAB، آنتی بادی خنثی می کند; IgT, therapeutic monoclonal antibody; CDC, complement-dependent cytotoxicity; mAb, monoclonal antibody; pAb, polyclonal antibody; ATA, anti-therapeutic antibody; NAb, neutralizing antibody; RF, rheumatoid factor; CIC, complement immune complex; NHS, norma
Selection Pressure From Neutralizing Antibodies Drives Sequence Evolution During Acute Infection With Hepatitis C Virus
Keywords: NAB، آنتی بادی خنثی می کند; GMT, geometric mean titer; HCV, hepatitis C virus; HCVpp, HCV pseudoparticles; HVR1, hypervariable region 1; ID50, 50% inhibitory dilution; nAb, neutralizing antibody; pp, pseudoparticle; RLU, relative light units
Effects of the number of amino acid residues in the signal segment upstream or downstream of the NS2B-3 cleavage site on production and secretion of prM/M-E virus-like particles of West Nile virus
Keywords: NAB، آنتی بادی خنثی می کند; West Nile virus; prM; VLPWNV, West Nile virus; VLP, virus-like particle; prM, precursor M; C, capsid; E, envelope; NAb, neutralizing antibody
In Silico Vaccine Design Based on Molecular Simulations of Rhinovirus Chimeras Presenting HIV-1 gp41 Epitopes
Keywords: NAB، آنتی بادی خنثی می کند; HIV, human immunodeficiency virus; MPER, membrane-proximal external region; nAb, neutralizing antibody; HRV14, human rhinovirus type 14; AGBNP, analytical generalized Born plus nonpolar; REMD, replica exchange molecular dynamics; MD, molecular dynamics; S
Neutralizing antibodies in patients with chronic hepatitis C infection treated with (Peg)-interferon/ribavirin
Keywords: NAB، آنتی بادی خنثی می کند; Nab, neutralizing antibody; HCV, hepatitis C virus; SVR, sustained virological response; SSCP, single strand conformation polymorphism; HCVpp, HCV pseudotype particles; ISDR, interferon sensitivity determining region; HCV-LPs, HCV-like particlesLiver dise
Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo
Keywords: NAB، آنتی بادی خنثی می کند; EIA, enzyme-linked immunosorbent assay; gp, glycoprotein; HCVpp, HCV pseudoparticle; HVR, hypervariable region; MAb, monoclonal antibody; nAb, neutralizing antibody; PBMC, peripheral blood mononuclear cell; PCR, polymerase chain reaction; sE2, soluble HCV
Discordant Role of CD4 T-Cell Response Relative to Neutralizing Antibody and CD8 T-Cell Responses in Acute Hepatitis C
Keywords: NAB، آنتی بادی خنثی می کند; AC, acute hepatitis with chronic evolution; AR, acute resolving hepatitis; HCVpp, hepatitis C virus pseudoparticle; nAb, neutralizing antibody; NS, nonstructural; SFU, spot-forming unit; SI, stimulation index; SOD, control superoxide dismutase; SVR, susta
Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody
Keywords: NAB، آنتی بادی خنثی می کند; HIV, human immunodeficiency virus; SIV, Simian immunodeficiency virus; Ab, antibody; NAb, neutralizing antibody; Env, envelope glycoprotein; PI, primary isolate; TCLA, T-cell line-adapted strainHIV-1; Entry; Envelope glycoprotein; Trimer; Phenotypic mixin
Confirming human antibody responses to a therapeutic monoclonal antibody using a statistical approach
Keywords: NAB، آنتی بادی خنثی می کند; ADAb, Anti-Drug antibody; CF, Correction factor; ELISA, Enzyme-linked immunosorbent assay; HQC, High quality control; LQC, Low quality control; MAb, Monoclonal antibody; MQC, Mid quality control; NAb, Neutralizing antibody; NQC, Negative quality control;
Analysis of neutralizing antibodies to therapeutic interferon-beta in multiple sclerosis patients: A comparison of three methods in a large Australasian cohort
Keywords: NAB، آنتی بادی خنثی می کند; IFNβ, interferon-beta; MS, multiple sclerosis; NAB, neutralizing antibody; CPE, cytopathic effect; MxA, myxovirus A; EMC, encephalomyocarditis; WISH, Wistar Institute Susan Hayflick; RT-PCR, reverse transcriptase-polymerase chain reaction; GAPDH, glyceral